Medesis Pharma S A : END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE TREATMENT OF ALZHEIMER'S DISEASE -October 17, 2023 at 03:19 am EDT
PRESS RELEASE END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE ...
Medesis Pharma Jacques Touchon Neuropharmacology Laboratory Of Mcgill University Professor Emeritus Of The University Montpellier Professor Emeritus Clinical Trials
Source: marketscreener.com